Liberty Mutual Group Asset Management Trimmed Its Idacorp (IDA) Position; Anaptysbio (ANAB) SI Decreased By 7.72%

October 13, 2017 - By Darrin Black

Anaptysbio Incorporated (NASDAQ:ANAB) had a decrease of 7.72% in short interest. ANAB’s SI was 248,700 shares in October as released by FINRA. Its down 7.72% from 269,500 shares previously. With 265,300 avg volume, 1 days are for Anaptysbio Incorporated (NASDAQ:ANAB)’s short sellers to cover ANAB’s short positions. The SI to Anaptysbio Incorporated’s float is 4.31%. About 1.78M shares traded or 237.06% up from the average. AnaptysBio Inc (NASDAQ:ANAB) has 0.00% since October 13, 2016 and is . It has underperformed by 16.70% the S&P500.

Liberty Mutual Group Asset Management Inc decreased Idacorp Inc (IDA) stake by 20% reported in 2017Q2 SEC filing. Liberty Mutual Group Asset Management Inc sold 4,487 shares as Idacorp Inc (IDA)’s stock rose 4.55%. The Liberty Mutual Group Asset Management Inc holds 17,949 shares with $1.53 million value, down from 22,436 last quarter. Idacorp Inc now has $4.55 billion valuation. The stock decreased 0.36% or $0.33 on October 13, reaching $90.34. About 150,090 shares traded. IDACORP Inc (NYSE:IDA) has risen 17.69% since October 13, 2016 and is uptrending. It has outperformed by 0.99% the S&P500.

Liberty Mutual Group Asset Management Inc increased Morgan Stanley (NYSE:MS) stake by 8,873 shares to 93,477 valued at $4.17M in 2017Q2. It also upped Ubs Group Ag (NYSE:UBS) stake by 69,810 shares and now owns 217,376 shares. Marathon Pete Corp (NYSE:MPC) was raised too.

Analysts await IDACORP Inc (NYSE:IDA) to report earnings on October, 26. They expect $1.69 earnings per share, up 2.42% or $0.04 from last year’s $1.65 per share. IDA’s profit will be $85.12M for 13.36 P/E if the $1.69 EPS becomes a reality. After $0.99 actual earnings per share reported by IDACORP Inc for the previous quarter, Wall Street now forecasts 70.71% EPS growth.

Investors sentiment increased to 1.75 in 2017 Q2. Its up 0.89, from 0.86 in 2017Q1. It is positive, as 15 investors sold IDA shares while 57 reduced holdings. 38 funds opened positions while 88 raised stakes. 37.82 million shares or 0.37% more from 37.69 million shares in 2017Q1 were reported. Hgk Asset Mgmt Inc owns 7,435 shares for 0.09% of their portfolio. Inv Counselors Of Maryland Ltd Liability Com invested 1.13% in IDACORP Inc (NYSE:IDA). Amer Svcs accumulated 10,678 shares or 0.36% of the stock. Clean Yield Group reported 0.13% in IDACORP Inc (NYSE:IDA). Proshare Ltd Company owns 8,779 shares. Lifeplan Fin Group stated it has 2,397 shares. Caprock Gru holds 9,178 shares or 0.17% of its portfolio. Oregon Public Employees Retirement Fund accumulated 18,565 shares. Citadel Advsrs Ltd Co holds 13,646 shares or 0% of its portfolio. Moreover, Ubs Asset Mgmt Americas Inc has 0% invested in IDACORP Inc (NYSE:IDA). Royal Savings Bank Of Canada owns 184,815 shares. Dubuque Bank holds 0.06% or 3,348 shares in its portfolio. First Washington stated it has 41,832 shares or 1.79% of all its holdings. Lord Abbett And Limited Liability Corp invested 0.14% in IDACORP Inc (NYSE:IDA). Teachers Retirement System Of The State Of Kentucky holds 9,270 shares.

Since June 1, 2017, it had 0 insider buys, and 2 sales for $158,751 activity. Grow Lisa A sold $106,349 worth of stock. On Thursday, June 1 the insider Malmen Jeffrey L sold $52,402.

AnaptysBio, Inc. is a United States biotechnology company. The company has market cap of $1.41 billion. The Firm is engaged in developing antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. It currently has negative earnings. The Firm develops its product candidates using its antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By :